{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:49:02Z","timestamp":1780541342948,"version":"3.54.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["R01 HL142627"],"award-info":[{"award-number":["R01 HL142627"]}]},{"name":"National Institute of Health","award":["HL156855"],"award-info":[{"award-number":["HL156855"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20TPA35490001"],"award-info":[{"award-number":["20TPA35490001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40291-022-00625-y","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T10:12:19Z","timestamp":1670926339000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target"],"prefix":"10.1007","volume":"27","author":[{"given":"Yura","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-7789","authenticated-orcid":false,"given":"Wuqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"issue":"18","key":"625_CR1","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.2021.5469","volume":"325","author":"FB Ahmad","year":"2021","unstructured":"Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA. 2021;325(18):1829\u201330.","journal-title":"JAMA"},{"issue":"6342","key":"625_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.aam5894","volume":"356","author":"E Tzahor","year":"2017","unstructured":"Tzahor E, Poss KD. Cardiac regeneration strategies: staying young at heart. Science. 2017;356(6342):1035\u20139.","journal-title":"Science"},{"issue":"7347","key":"625_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature10147","volume":"473","author":"MA Laflamme","year":"2011","unstructured":"Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473(7347):326\u201335.","journal-title":"Nature"},{"issue":"7","key":"625_CR4","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","volume":"161","author":"O Bergmann","year":"2015","unstructured":"Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, et al. Dynamics of cell generation and turnover in the human heart. Cell. 2015;161(7):1566\u201375.","journal-title":"Cell"},{"issue":"17","key":"625_CR5","doi-asserted-by":"publisher","first-page":"9206","DOI":"10.3390\/ijms22179206","volume":"22","author":"Y Kim","year":"2021","unstructured":"Kim Y, Zharkinbekov Z, Sarsenova M, Yeltay G, Saparov A. Recent advances in gene therapy for cardiac tissue regeneration. Int J Mol Sci. 2021;22(17):9206.","journal-title":"Int J Mol Sci"},{"issue":"6020","key":"625_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1200708","volume":"331","author":"ER Porrello","year":"2011","unstructured":"Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331(6020):1078\u201380.","journal-title":"Science"},{"issue":"24","key":"625_CR7","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1161\/CIRCULATIONAHA.118.034886","volume":"138","author":"W Zhu","year":"2018","unstructured":"Zhu W, Zhang E, Zhao M, Chong Z, Fan C, Tang Y, et al. Regenerative potential of neonatal porcine hearts. Circulation. 2018;138(24):2809\u201316.","journal-title":"Circulation"},{"issue":"2","key":"625_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00424-017-2061-4","volume":"470","author":"M Hesse","year":"2018","unstructured":"Hesse M, Welz A, Fleischmann BK. Heart regeneration and the cardiomyocyte cell cycle. Pflug Arch Eur J Physiol. 2018;470(2):241\u20138.","journal-title":"Pflug Arch Eur J Physiol"},{"issue":"5","key":"625_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015636","volume":"4","author":"M Tonsho","year":"2014","unstructured":"Tonsho M, Michel S, Ahmed Z, Alessandrini A, Madsen JC. Heart transplantation: challenges facing the field. Cold Spring Harb Perspect Med. 2014;4(5): a015636.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"625_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2015.12.025","volume":"82","author":"HK Awada","year":"2016","unstructured":"Awada HK, Hwang MP, Wang Y. Towards comprehensive cardiac repair and regeneration after myocardial infarction: aspects to consider and proteins to deliver. Biomaterials. 2016;82:94\u2013112.","journal-title":"Biomaterials"},{"issue":"6","key":"625_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","volume":"12","author":"JC Garbern","year":"2013","unstructured":"Garbern JC, Lee RT. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013;12(6):689\u201398.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"625_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-018-1011-x","volume":"20","author":"JP Leach","year":"2018","unstructured":"Leach JP, Martin JF. Cardiomyocyte proliferation for therapeutic regeneration. Curr Cardiol Rep. 2018;20(8):1\u20138.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"625_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/FJC.0000000000001072","volume":"78","author":"AE L\u00f3pez","year":"2021","unstructured":"L\u00f3pez AE, del Rosario BM, Cuniberti L, Crottogini AJ, Olea FD, Locatelli P. Gene therapy: targeting cardiomyocyte proliferation to repopulate the ischemic heart. J Cardiovasc Pharmacol. 2021;78(3):346\u201360.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"625_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto H, Olson EN, Bassel-Duby R. Therapeutic approaches for cardiac regeneration and repair. Nat Rev Cardiol. 2018;15(10):585\u2013600.","journal-title":"Nat Rev Cardiol"},{"issue":"239","key":"625_CR15","doi-asserted-by":"publisher","first-page":"239rv1-rv1","DOI":"10.1126\/scitranslmed.3006681","volume":"6","author":"Z Lin","year":"2014","unstructured":"Lin Z, Pu WT. Strategies for cardiac regeneration and repair. Sci Transl Med. 2014;6(239):239rv1-rv1.","journal-title":"Sci Transl Med"},{"issue":"7","key":"625_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"625_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.594226","volume":"8","author":"M-T Zhao","year":"2020","unstructured":"Zhao M-T, Ye S, Su J, Garg V. Cardiomyocyte proliferation and maturation: two sides of the same coin for heart regeneration. Front Cell Dev Biol. 2020;8: 594226.","journal-title":"Front Cell Dev Biol"},{"issue":"5923","key":"625_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnab\u00e9-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98\u2013102.","journal-title":"Science"},{"issue":"1 Suppl","key":"625_CR19","first-page":"I206","volume":"114","author":"YJ Woo","year":"2006","unstructured":"Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, et al. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation. 2006;114(1 Suppl):I206\u201313.","journal-title":"Circulation"},{"issue":"34","key":"625_CR20","doi-asserted-by":"publisher","first-page":"35858","DOI":"10.1074\/jbc.M404975200","volume":"279","author":"HW Chaudhry","year":"2004","unstructured":"Chaudhry HW, Dashoush NH, Tang H, Zhang L, Wang X, Wu EX, et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem. 2004;279(34):35858\u201366.","journal-title":"J Biol Chem"},{"issue":"11","key":"625_CR21","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1172\/JCI119453","volume":"99","author":"MH Soonpaa","year":"1997","unstructured":"Soonpaa MH, Koh GY, Pajak L, Jing S, Wang H, Franklin MT, et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Investig. 1997;99(11):2644\u201354.","journal-title":"J Clin Investig"},{"issue":"1","key":"625_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.RES.0000152326.91223.4F","volume":"96","author":"KB Pasumarthi","year":"2005","unstructured":"Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res. 2005;96(1):110\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"625_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed TMA, Ang YS, Radzinsky E, Zhou P, Huang Y, Elfenbein A, et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell. 2018;173(1):104-116.e12.","journal-title":"Cell"},{"issue":"10","key":"625_CR24","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1074\/jbc.M110.184549","volume":"286","author":"V Di Stefano","year":"2011","unstructured":"Di Stefano V, Giacca M, Capogrossi MC, Crescenzi M, Martelli F. Knockdown of cyclin-dependent kinase inhibitors induces cardiomyocyte re-entry in the cell cycle. J Biol Chem. 2011;286(10):8644\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"625_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.bbrc.2013.12.109","volume":"443","author":"S Tane","year":"2014","unstructured":"Tane S, Ikenishi A, Okayama H, Iwamoto N, Nakayama KI, Takeuchi T. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes. Biochem Biophys Res Commun. 2014;443(3):1105\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7448","key":"625_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature12054","volume":"497","author":"AI Mahmoud","year":"2013","unstructured":"Mahmoud AI, Kocabas F, Muralidhar SA, Kimura W, Koura AS, Thet S, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature. 2013;497(7448):249\u201353.","journal-title":"Nature"},{"issue":"12","key":"625_CR27","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1515\/BC.2007.159","volume":"388","author":"I Wierstra","year":"2007","unstructured":"Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388(12):1257\u201374.","journal-title":"Biol Chem"},{"key":"625_CR28","doi-asserted-by":"crossref","unstructured":"Zuppo DA, Missinato MA, Santana-Santos L, Li G, Benos PV, Tsang M. Foxm1 drives cardiomyocyte proliferation in adult zebrafish after cardiac injury. bioRxiv (2022).","DOI":"10.1101\/2022.06.22.497073"},{"issue":"11","key":"625_CR29","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1172\/JCI119817","volume":"100","author":"R Agah","year":"1997","unstructured":"Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, et al. Adenoviral delivery of E2F\u20131 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Investig. 1997;100(11):2722\u20138.","journal-title":"J Clin Investig"},{"issue":"2","key":"625_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/cvr\/cvn194","volume":"80","author":"H Ebelt","year":"2008","unstructured":"Ebelt H, Zhang Y, Kampke A, Xu J, Schlitt A, Buerke M, et al. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo. Cardiovasc Res. 2008;80(2):219\u201326.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"625_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/01.RES.0000159705.17322.57","volume":"96","author":"H Ebelt","year":"2005","unstructured":"Ebelt H, Hufnagel N, Neuhaus P, Neuhaus H, Gajawada P, Simm A, et al. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis. Circ Res. 2005;96(5):509\u201317.","journal-title":"Circ Res"},{"issue":"11","key":"625_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.115.019357","volume":"133","author":"FL Xiang","year":"2016","unstructured":"Xiang FL, Guo M, Yutzey KE. Overexpression of Tbx20 in adult cardiomyocytes promotes proliferation and improves cardiac function after myocardial infarction. Circulation. 2016;133(11):1081\u201392.","journal-title":"Circulation"},{"issue":"39","key":"625_CR33","doi-asserted-by":"publisher","first-page":"14471","DOI":"10.1073\/pnas.0602543103","volume":"103","author":"E Bisping","year":"2006","unstructured":"Bisping E, Ikeda S, Kong Sek W, Tarnavski O, Bodyak N, McMullen Julie R, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci. 2006;103(39):14471\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"625_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000215985.18538.c4","volume":"98","author":"T Oka","year":"2006","unstructured":"Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 2006;98(6):837\u201345.","journal-title":"Circ Res"},{"issue":"2","key":"625_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15252\/emmm.201606602","volume":"9","author":"M Malek Mohammadi","year":"2017","unstructured":"Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf-Klingebiel M, Gigina A, et al. The transcription factor GATA4 promotes myocardial regeneration in neonatal mice. EMBO Mol Med. 2017;9(2):265\u201379.","journal-title":"EMBO Mol Med"},{"issue":"19","key":"625_CR36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.198937","volume":"148","author":"DEM de Bakker","year":"2021","unstructured":"de Bakker DEM, Bouwman M, Dronkers E, Sim\u00f5es FC, Riley PR, Goumans MJ, et al. Prrx1b restricts fibrosis and promotes Nrg1-dependent cardiomyocyte proliferation during zebrafish heart regeneration. Development. 2021;148(19): 198937.","journal-title":"Development"},{"issue":"7429","key":"625_CR37","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11739","volume":"492","author":"A Eulalio","year":"2012","unstructured":"Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012;492(7429):376\u201381.","journal-title":"Nature"},{"issue":"201","key":"625_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijcard.2015.06.163","volume":"15","author":"D Liang","year":"2015","unstructured":"Liang D, Li J, Wu Y, Zhen L, Li C, Qi M, et al. miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2. Int J Cardiol. 2015;15(201):38\u201348.","journal-title":"Int J Cardiol"},{"issue":"12","key":"625_CR39","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCRESAHA.112.300658","volume":"112","author":"J Chen","year":"2013","unstructured":"Chen J, Huang ZP, Seok HY, Ding J, Kataoka M, Zhang Z, et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res. 2013;112(12):1557\u201366.","journal-title":"Circ Res"},{"issue":"21","key":"625_CR40","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1128\/MCB.00398-08","volume":"28","author":"A Barroso-delJesus","year":"2008","unstructured":"Barroso-delJesus A, Romero-L\u00f3pez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, et al. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol. 2008;28(21):6609\u201319.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"625_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/CIRCRESAHA.118.314223","volume":"125","author":"A Borden","year":"2019","unstructured":"Borden A, Kurian J, Nickoloff E, Yang Y, Troupes CD, Ibetti J, et al. Transient introduction of miR-294 in the heart promotes cardiomyocyte cell cycle reentry after injury. Circ Res. 2019;125(1):14\u201325.","journal-title":"Circ Res"},{"issue":"6","key":"625_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCRESAHA.111.248880","volume":"109","author":"ER Porrello","year":"2011","unstructured":"Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ, et al. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res. 2011;109(6):670\u20139.","journal-title":"Circ Res"},{"issue":"1","key":"625_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1073\/pnas.1208863110","volume":"110","author":"ER Porrello","year":"2013","unstructured":"Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D, et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci USA. 2013;110(1):187\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"625_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41467-018-03019-z","volume":"9","author":"W Huang","year":"2018","unstructured":"Huang W, Feng Y, Liang J, Yu H, Wang C, Wang B, et al. Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nat Commun. 2018;9(1):700.","journal-title":"Nat Commun"},{"issue":"6","key":"625_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11936-016-0461-y","volume":"18","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Leach J, Wang J, Martin JF. Hippo\/Yap signaling in cardiac development and regeneration. Curr Treat Options Cardiovasc Med. 2016;18(6):1\u20139.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"34","key":"625_CR46","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"M Xin","year":"2013","unstructured":"Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA. 2013;110(34):13839\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"625_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12(1):9\u201318.","journal-title":"Cell Res"},{"issue":"12","key":"625_CR48","first-page":"15947","volume":"8","author":"J Zhao","year":"2015","unstructured":"Zhao J, Li L, Peng L. MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K\/AKT signaling pathway. Int J Clin Exp Pathol. 2015;8(12):15947\u201353.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"625_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35\u201345.","journal-title":"Circ Res"},{"issue":"1","key":"625_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"625_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41422-020-00411-7","volume":"31","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zhou L, Liu H, Duan R, Zhou H, Zhang F, et al. LRP6 downregulation promotes cardiomyocyte proliferation and heart regeneration. Cell Res. 2021;31(4):450\u201362.","journal-title":"Cell Res"},{"key":"625_CR52","first-page":"772","volume":"22","author":"S Qu","year":"2022","unstructured":"Qu S, Liao Q, Yu C, Chen Y, Luo H, Xia X, et al. LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis. Bosn J Basic Med Sci. 2022;22:772\u201383.","journal-title":"Bosn J Basic Med Sci"},{"issue":"6436","key":"625_CR53","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.aar2038","volume":"364","author":"K Hirose","year":"2019","unstructured":"Hirose K, Payumo AY, Cutie S, Hoang A, Zhang H, Guyot R, et al. Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science. 2019;364(6436):184\u20138.","journal-title":"Science"},{"issue":"12","key":"625_CR54","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.121.054846","volume":"144","author":"AY Payumo","year":"2021","unstructured":"Payumo AY, Chen X, Hirose K, Chen X, Hoang A, Khyeam S, et al. Adrenergic-thyroid hormone interactions drive postnatal thermogenesis and loss of mammalian heart regenerative capacity. Circulation. 2021;144(12):1000\u20133.","journal-title":"Circulation"},{"issue":"12","key":"625_CR55","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/cvr\/cvab340","volume":"118","author":"F Hubert","year":"2022","unstructured":"Hubert F, Payan SM, Pelce E, Bouchard L, Sturny R, Lenfant N, et al. FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis. Cardiovasc Res. 2022;118(12):2625\u201337.","journal-title":"Cardiovasc Res"},{"key":"625_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fgene.2018.00599","volume":"9","author":"F Hubert","year":"2018","unstructured":"Hubert F, Payan SM, Rochais F. FGF10 signaling in heart development, homeostasis, disease and repair. Front Genet. 2018;9:599.","journal-title":"Front Genet"},{"issue":"20","key":"625_CR57","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.7150\/thno.44281","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li Y, Feng J, Liu W, Li Y, Liu J, et al. Mydgf promotes cardiomyocyte proliferation and neonatal heart regeneration. Theranostics. 2020;10(20):9100\u201312.","journal-title":"Theranostics."},{"issue":"2","key":"625_CR58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","volume":"138","author":"K Bersell","year":"2009","unstructured":"Bersell K, Arab S, Haring B, K\u00fchn B. Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138(2):257\u201370.","journal-title":"Cell"},{"issue":"8","key":"625_CR59","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nm1619","volume":"13","author":"B K\u00fchn","year":"2007","unstructured":"K\u00fchn B, Del Monte F, Hajjar RJ, Chang Y-S, Lebeche D, Arab S, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13(8):962\u20139.","journal-title":"Nat Med"},{"issue":"4","key":"625_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.celrep.2019.06.065","volume":"28","author":"Z Yue","year":"2019","unstructured":"Yue Z, Chen J, Lian H, Pei J, Li Y, Chen X, et al. PDGFR-\u03b2 signaling regulates cardiomyocyte proliferation and myocardial regeneration. Cell Rep. 2019;28(4):966\u201378.","journal-title":"Cell Rep"},{"issue":"6","key":"625_CR61","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1096\/fj.201801330RR","volume":"33","author":"IM Lindgren","year":"2019","unstructured":"Lindgren IM, Drake RR, Chattergoon NN, Thornburg KL. Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes. FASEB J. 2019;33(6):7417\u201326.","journal-title":"FASEB J"},{"issue":"20","key":"625_CR62","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.120.049952","volume":"143","author":"J Bae","year":"2021","unstructured":"Bae J, Salamon RJ, Brandt EB, Paltzer WG, Zhang Z, Britt EC, et al. Malonate promotes adult cardiomyocyte proliferation and heart regeneration. Circulation. 2021;143(20):1973\u201386.","journal-title":"Circulation"},{"issue":"1","key":"625_CR63","doi-asserted-by":"publisher","first-page":"H24","DOI":"10.1152\/ajpheart.00521.2018","volume":"316","author":"DJ Wodsedalek","year":"2019","unstructured":"Wodsedalek DJ, Paddock SJ, Wan TC, Auchampach JA, Kenarsary A, Tsaih SW, et al. IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration. Am J Physiol Heart Circ Physiol. 2019;316(1):H24\u201334.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"625_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2021.07.012","volume":"161","author":"SJ Paddock","year":"2021","unstructured":"Paddock SJ, Swift SK, Alencar-Almeida V, Kenarsary A, Alvarez-Argote S, Flinn MA, et al. IL4R\u03b1 signaling promotes neonatal cardiac regeneration and cardiomyocyte cell cycle activity. J Mol Cell Cardiol. 2021;161:62\u201374.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"625_CR65","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","volume":"11","author":"MS Al-Dosari","year":"2009","unstructured":"Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009;11(4):671\u201381.","journal-title":"AAPS J"},{"issue":"1\u20133","key":"625_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0168-3659(01)00267-X","volume":"72","author":"WT Godbey","year":"2001","unstructured":"Godbey WT, Mikos AG. Recent progress in gene delivery using non-viral transfer complexes. J Control Release. 2001;72(1\u20133):115\u201325.","journal-title":"J Control Release"},{"issue":"1","key":"625_CR67","first-page":"GE01-6","volume":"9","author":"M Ramamoorth","year":"2015","unstructured":"Ramamoorth M, Narvekar A. Non viral vectors in gene therapy- an overview. J Clin Diagn Res. 2015;9(1):GE01-6.","journal-title":"J Clin Diagn Res"},{"issue":"9 Suppl","key":"625_CR68","first-page":"I157","volume":"112","author":"M Gy\u00f6ngy\u00f6si","year":"2005","unstructured":"Gy\u00f6ngy\u00f6si M, Khorsand A, Zamini S, Sperker W, Strehblow C, Kastrup J, et al. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation. 2005;112(9 Suppl):I157\u201365.","journal-title":"Circulation"},{"issue":"24","key":"625_CR69","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/sj.gt.3301844","volume":"9","author":"R Laguens","year":"2002","unstructured":"Laguens R, Cabeza Meckert P, Vera Janavel G, Del Valle H, Lascano E, Negroni J, et al. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Ther. 2002;9(24):1676\u201381.","journal-title":"Gene Ther"},{"issue":"15","key":"625_CR70","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/sj.gt.3302708","volume":"13","author":"G Vera Janavel","year":"2006","unstructured":"Vera Janavel G, Crottogini A, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M, et al. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther. 2006;13(15):1133\u201342.","journal-title":"Gene Ther"},{"key":"625_CR71","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/IJN.S366962","volume":"17","author":"S Scalzo","year":"2022","unstructured":"Scalzo S, Santos AK, Ferreira HAS, Costa PA, Prazeres P, da Silva NJA, et al. Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes. Int J Nanomedicine. 2022;17:2865\u201381.","journal-title":"Int J Nanomedicine"},{"key":"625_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12950-015-0053-8","volume":"12","author":"LS Zhou","year":"2015","unstructured":"Zhou LS, Zhao GL, Liu Q, Jiang SC, Wang Y, Zhang DM. Silencing collapsin response mediator protein-2 reprograms macrophage phenotype and improves infarct healing in experimental myocardial infarction model. J Inflamm (Lond). 2015;12:11.","journal-title":"J Inflamm (Lond)"},{"key":"625_CR73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/nnm.13.188","volume":"9","author":"Q Yin","year":"2014","unstructured":"Yin Q, Pei Z, Wang H, Zhao Y. Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model. Int J Nanomedicine. 2014;9:17\u201326.","journal-title":"Int J Nanomedicine"},{"issue":"257","key":"625_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2017.01.001","volume":"10","author":"T Ben-Mordechai","year":"2017","unstructured":"Ben-Mordechai T, Kain D, Holbova R, Landa N, Levin LP, Elron-Gross I, et al. Targeting and modulating infarct macrophages with hemin formulated in designed lipid-based particles improves cardiac remodeling and function. J Control Release. 2017;10(257):21\u201331.","journal-title":"J Control Release"},{"issue":"6","key":"625_CR75","doi-asserted-by":"publisher","first-page":"H629","DOI":"10.1152\/ajpheart.00126.2012","volume":"303","author":"C-H Su","year":"2012","unstructured":"Su C-H, Wu Y-J, Wang H-H, Yeh H-I. Nonviral gene therapy targeting cardiovascular system. Am J Physiol Heart Circ Physiol. 2012;303(6):H629\u201338.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"625_CR76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/cvr\/cvv205","volume":"108","author":"MY Rincon","year":"2015","unstructured":"Rincon MY, VandenDriessche T, Chuah MK. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res. 2015;108(1):4\u201320.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"625_CR77","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1586\/14779072.2013.818813","volume":"11","author":"MC Scimia","year":"2013","unstructured":"Scimia MC, Cannavo A, Koch WJ. Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium. Expert Rev Cardiovasc Ther. 2013;11(8):999\u20131013.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"Suppl","key":"625_CR78","first-page":"3","volume":"15","author":"M Saffari","year":"2016","unstructured":"Saffari M, Moghimi HR, Dass CR. Barriers to liposomal gene delivery: from application site to the target. Iran J Pharm Res. 2016;15(Suppl):3\u201317.","journal-title":"Iran J Pharm Res"},{"key":"625_CR79","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.2147\/IJN.S141549","volume":"12","author":"M Shao","year":"2017","unstructured":"Shao M, Yang W, Han G. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles. Int J Nanomedicine. 2017;12:7121\u201330.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"625_CR80","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1080\/10717544.2016.1223218","volume":"23","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23(9):3696\u2013703.","journal-title":"Drug Deliv"},{"key":"625_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biopha.2017.02.029","volume":"89","author":"Z Dong","year":"2017","unstructured":"Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297\u2013304.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"625_CR82","doi-asserted-by":"publisher","first-page":"20467","DOI":"10.1038\/srep20467","volume":"6","author":"G Ikeda","year":"2016","unstructured":"Ikeda G, Matoba T, Nakano Y, Nagaoka K, Ishikita A, Nakano K, et al. Nanoparticle-mediated targeting of cyclosporine a enhances cardioprotection against ischemia\u2013reperfusion injury through inhibition of mitochondrial permeability transition pore opening. Sci Rep. 2016;6(1):20467.","journal-title":"Sci Rep"},{"issue":"6","key":"625_CR83","doi-asserted-by":"publisher","first-page":"29601","DOI":"10.1038\/srep29601","volume":"11","author":"Y Nakano","year":"2016","unstructured":"Nakano Y, Matoba T, Tokutome M, Funamoto D, Katsuki S, Ikeda G, et al. Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia\u2013reperfusion injury by antagonizing monocyte-mediated inflammation. Sci Rep. 2016;11(6):29601.","journal-title":"Sci Rep"},{"issue":"4","key":"625_CR84","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1536\/ihj.16-457","volume":"58","author":"Y Mao","year":"2017","unstructured":"Mao Y, Koga JI, Tokutome M, Matoba T, Ikeda G, Nakano K, et al. Nanoparticle-mediated delivery of pitavastatin to monocytes\/macrophages inhibits left ventricular remodeling after acute myocardial infarction by inhibiting monocyte-mediated inflammation. Int Heart J. 2017;58(4):615\u201323.","journal-title":"Int Heart J"},{"issue":"7","key":"625_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132451","volume":"10","author":"K Nagaoka","year":"2015","unstructured":"Nagaoka K, Matoba T, Mao Y, Nakano Y, Ikeda G, Egusa S, et al. A new therapeutic modality for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin induces cardioprotection from ischemia\u2013reperfusion injury via activation of PI3K\/Akt pathway and anti-inflammation in a rat model. PLoS\u00a0One. 2015;10(7): e0132451.","journal-title":"PLoS\u00a0One"},{"issue":"9","key":"625_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162425","volume":"11","author":"K Ichimura","year":"2016","unstructured":"Ichimura K, Matoba T, Nakano K, Tokutome M, Honda K, Koga J, et al. A translational study of a new therapeutic approach for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin into reperfused myocardium reduces ischemia\u2013reperfusion injury in a preclinical porcine model. PLoS\u00a0One. 2016;11(9): e0162425.","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"625_CR87","doi-asserted-by":"publisher","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","volume":"314","author":"Y Oduk","year":"2018","unstructured":"Oduk Y, Zhu W, Kannappan R, Zhao M, Borovjagin AV, Oparil S, et al. VEGF nanoparticles repair the heart after myocardial infarction. Am J Physiol Heart Circ Physiol. 2018;314(2):H278\u201384.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"625_CR88","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jconrel.2013.04.022","volume":"170","author":"MY Chang","year":"2013","unstructured":"Chang MY, Yang YJ, Chang CH, Tang AC, Liao WY, Cheng FY, et al. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J Control Release. 2013;170(2):287\u201394.","journal-title":"J Control Release"},{"issue":"2","key":"625_CR89","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17458080.2015.1029015","volume":"11","author":"K Yu","year":"2016","unstructured":"Yu K, Wu S, Li H. A chitosan-graft-PEI-eprosartan conjugate for cardiomyocyte-targeted VEGF plasmid delivery in myocardial ischemia gene therapy. J Exp Nanosci. 2016;11(2):81\u201396.","journal-title":"J Exp Nanosci"},{"issue":"5","key":"625_CR90","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/bit.21036","volume":"95","author":"P Xu","year":"2006","unstructured":"Xu P, Li SY, Li Q, Ren J, Van Kirk EA, Murdoch WJ, et al. Biodegradable cationic polyester as an efficient carrier for gene delivery to neonatal cardiomyocytes. Biotechnol Bioeng. 2006;95(5):893\u2013903.","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"625_CR91","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/jgm.1320","volume":"11","author":"H Kim","year":"2009","unstructured":"Kim H, Kim HA, Bae YM, Choi JS, Lee M. Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes. J Gene Med. 2009;11(6):515\u201322.","journal-title":"J Gene Med"},{"issue":"5","key":"625_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/am.2014.19","volume":"6","author":"G Camci-Unal","year":"2014","unstructured":"Camci-Unal G, Annabi N, Dokmeci MR, Liao R, Khademhosseini A. Hydrogels for cardiac tissue engineering. NPG Asia Mater. 2014;6(5): e99-e.","journal-title":"NPG Asia Mater"},{"key":"625_CR93","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41551-017-0157-y","volume":"1","author":"LL Wang","year":"2017","unstructured":"Wang LL, Liu Y, Chung JJ, Wang T, Gaffey AC, Lu M, et al. Local and sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischemic injury. Nat Biomed Eng. 2017;1:983\u201392.","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"625_CR94","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1021\/acsnano.9b03343","volume":"13","author":"H Yang","year":"2019","unstructured":"Yang H, Qin X, Wang H, Zhao X, Liu Y, Wo HT, et al. An in vivo miRNA delivery system for restoring infarcted myocardium. ACS Nano. 2019;13(9):9880\u201394.","journal-title":"ACS Nano"},{"issue":"9","key":"625_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd6740","volume":"7","author":"Y Li","year":"2021","unstructured":"Li Y, Chen X, Jin R, Chen L, Dang M, Cao H, et al. Injectable hydrogel with MSNs\/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Sci Adv. 2021;7(9): eabd6740.","journal-title":"Sci Adv"},{"issue":"7","key":"625_CR96","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jcmg.2009.04.008","volume":"2","author":"H Fujii","year":"2009","unstructured":"Fujii H, Sun Z, Li SH, Wu J, Fazel S, Weisel RD, et al. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc Imaging. 2009;2(7):869\u201379.","journal-title":"JACC Cardiovasc Imaging"},{"key":"625_CR97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2021.06.021","volume":"122","author":"W Zhou","year":"2022","unstructured":"Zhou W, Ma T, Ding S. Non-viral approaches for somatic cell reprogramming into cardiomyocytes. Semin Cell Dev Biol. 2022;122:28\u201336.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"625_CR98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1385\/MB:28:1:21","volume":"28","author":"S Djurovic","year":"2004","unstructured":"Djurovic S, Iversen N, Jeansson S, Hoover F, Christensen G. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol. 2004;28(1):21\u201331.","journal-title":"Mol Biotechnol"},{"issue":"2","key":"625_CR99","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/FJC.0b013e3182a2e8b8","volume":"63","author":"A Yerevanian","year":"2014","unstructured":"Yerevanian A, Yerevanian A, Hajjar RJ. Progress in gene therapy for heart failure. J Cardiovasc Pharmacol. 2014;63(2):95\u2013106.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"625_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1172\/JCI62837","volume":"123","author":"RJ Hajjar","year":"2013","unstructured":"Hajjar RJ. Potential of gene therapy as a treatment for heart failure. J Clin Investig. 2013;123(1):53\u201361.","journal-title":"J Clin Investig"},{"issue":"2","key":"625_CR101","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00007890-199707270-00007","volume":"64","author":"C Schmid","year":"1997","unstructured":"Schmid C, Heemann U, Tilney NL. Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation. Transplantation. 1997;64(2):222\u20138.","journal-title":"Transplantation"},{"issue":"33","key":"625_CR102","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","volume":"38","author":"J Hartikainen","year":"2017","unstructured":"Hartikainen J, Hassinen I, Hedman A, Kivel\u00e4 A, Saraste A, Knuuti J, et al. Adenoviral intramyocardial VEGF-D\u0394N\u0394C gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up. Eur Heart J. 2017;38(33):2547\u201355.","journal-title":"Eur Heart J"},{"issue":"2","key":"625_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2016.0008","volume":"1","author":"HK Hammond","year":"2016","unstructured":"Hammond HK, Penny WF, Traverse JH, Henry TD, Watkins MW, Yancy CW, et al. Intracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trial. JAMA Cardiol. 2016;1(2):163\u201371.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"625_CR104","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1073\/pnas.1018925108","volume":"108","author":"Z Tao","year":"2011","unstructured":"Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T, et al. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci USA. 2011;108(5):2064\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"625_CR105","doi-asserted-by":"publisher","first-page":"R494","DOI":"10.1152\/ajpregu.00460.2005","volume":"290","author":"MJ Post","year":"2006","unstructured":"Post MJ, Sato K, Murakami M, Bao J, Tirziu D, Pearlman JD, et al. Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R494\u2013500.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"625_CR106","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/104303404323142024","volume":"15","author":"MH Gao","year":"2004","unstructured":"Gao MH, Lai NC, McKirnan MD, Roth DA, Rubanyi GM, Dalton N, et al. Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data. Hum Gene Ther. 2004;15(6):574\u201387.","journal-title":"Hum Gene Ther"},{"issue":"11","key":"625_CR107","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/hc1102.105595","volume":"105","author":"CL Grines","year":"2002","unstructured":"Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002;105(11):1291\u20137.","journal-title":"Circulation"},{"issue":"21","key":"625_CR108","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","volume":"13","author":"DJ Stewart","year":"2006","unstructured":"Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006;13(21):1503\u201311.","journal-title":"Gene Ther"},{"issue":"224","key":"625_CR109","doi-asserted-by":"publisher","first-page":"224ra27","DOI":"10.1126\/scitranslmed.3007668","volume":"6","author":"SD Shapiro","year":"2014","unstructured":"Shapiro SD, Ranjan AK, Kawase Y, Cheng RK, Kara RJ, Bhattacharya R, et al. Cyclin A2 induces cardiac regeneration after myocardial infarction through cytokinesis of adult cardiomyocytes. Sci Transl Med. 2014;6(224):224ra27.","journal-title":"Sci Transl Med"},{"issue":"1","key":"625_CR110","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1161\/01.RES.0000049105.15329.1C","volume":"92","author":"M Tamamori-Adachi","year":"2003","unstructured":"Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, et al. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res. 2003;92(1):e12\u20139.","journal-title":"Circ Res"},{"issue":"12","key":"625_CR111","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004;78(12):6381\u20138.","journal-title":"J Virol"},{"issue":"18","key":"625_CR112","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA. 2002;99(18):11854\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"625_CR113","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1752-8062.2010.00190.x","volume":"3","author":"C Zincarelli","year":"2010","unstructured":"Zincarelli C, Soltys S, Rengo G, Koch WJ, Rabinowitz JE. Comparative cardiac gene delivery of adeno-associated virus serotypes 1\u20139 reveals that AAV6 mediates the most efficient transduction in mouse heart. Clin Transl Sci. 2010;3(3):81\u20139.","journal-title":"Clin Transl Sci"},{"issue":"11","key":"625_CR114","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.114.302331","volume":"114","author":"S Zacchigna","year":"2014","unstructured":"Zacchigna S, Zentilin L, Giacca M. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system. Circ Res. 2014;114(11):1827\u201346.","journal-title":"Circ Res"},{"issue":"1","key":"625_CR115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther. 2006;14(1):45\u201353.","journal-title":"Mol Ther"},{"issue":"10024","key":"625_CR116","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet. 2016;387(10024):1178\u201386.","journal-title":"Lancet"},{"issue":"10","key":"625_CR117","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.119.044484","volume":"142","author":"Y Li","year":"2020","unstructured":"Li Y, Feng J, Song S, Li H, Yang H, Zhou B, et al. gp130 controls cardiomyocyte proliferation and heart regeneration. Circulation. 2020;142(10):967\u201382.","journal-title":"Circulation"},{"issue":"24","key":"625_CR118","doi-asserted-by":"publisher","first-page":"10892","DOI":"10.7150\/thno.47913","volume":"10","author":"F Wang","year":"2020","unstructured":"Wang F, Liu S, Pei J, Cai L, Liu N, Liang T, et al. LPA(3)-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice. Theranostics. 2020;10(24):10892\u2013907.","journal-title":"Theranostics"},{"issue":"7756","key":"625_CR119","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia K, Prosdocimo G, Aquaro GD, Carlucci L, Zentilin L, Secco I, et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature. 2019;569(7756):418\u201322.","journal-title":"Nature"},{"issue":"10","key":"625_CR120","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012239","volume":"8","author":"JM Kieserman","year":"2019","unstructured":"Kieserman JM, Myers VD, Dubey P, Cheung JY, Feldman AM. Current landscape of heart failure gene therapy. J Am Heart Assoc. 2019;8(10): e012239.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"625_CR121","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/jgm.2691","volume":"15","author":"GJ McGarrity","year":"2013","unstructured":"McGarrity GJ, Hoyah G, Winemiller A, Andre K, Stein D, Blick G, et al. Patient monitoring and follow-up in lentiviral clinical trials. J Gene Med. 2013;15(2):78\u201382.","journal-title":"J Gene Med"},{"issue":"7313","key":"625_CR122","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, et al. Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature. 2010;467(7313):318\u201322.","journal-title":"Nature"},{"issue":"5954","key":"625_CR123","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326(5954):818\u201323.","journal-title":"Science"},{"issue":"6148","key":"625_CR124","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341(6148):1233158.","journal-title":"Science"},{"issue":"6148","key":"625_CR125","doi-asserted-by":"publisher","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott\u2013Aldrich syndrome. Science. 2013;341(6148):1233151.","journal-title":"Science"},{"issue":"1","key":"625_CR126","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/CIRCRESAHA.117.311504","volume":"122","author":"W Zhu","year":"2018","unstructured":"Zhu W, Zhao M, Mattapally S, Chen S, Zhang J. CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle. Circ Res. 2018;122(1):88\u201396.","journal-title":"Circ Res"},{"issue":"279","key":"625_CR127","doi-asserted-by":"publisher","first-page":"279ra38","DOI":"10.1126\/scitranslmed.3010841","volume":"7","author":"Y Tian","year":"2015","unstructured":"Tian Y, Liu Y, Wang T, Zhou N, Kong J, Chen L, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci Transl Med. 2015;7(279):279ra38.","journal-title":"Sci Transl Med"},{"issue":"17","key":"625_CR128","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.121.057641","volume":"145","author":"RRE Abouleisa","year":"2022","unstructured":"Abouleisa RRE, Salama ABM, Ou Q, Tang XL, Solanki M, Guo Y, et al. Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure. Circulation. 2022;145(17):1339\u201355.","journal-title":"Circulation"},{"key":"625_CR129","first-page":"135","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Guan Q, Dai S, Wei W, Zhang Y. Integrin \u03b21 increases stem cell survival and cardiac function after myocardial infarction. Front Pharmacol. 2017;8:135.","journal-title":"Front Pharmacol"},{"issue":"12","key":"625_CR130","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","volume":"58","author":"R Schlimgen","year":"2016","unstructured":"Schlimgen R, Howard J, Wooley D, Thompson M, Baden LR, Yang OO, et al. Risks associated with lentiviral vector exposures and prevention strategies. J Occup Environ Med. 2016;58(12):1159\u201366.","journal-title":"J Occup Environ Med"},{"issue":"4","key":"625_CR131","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.00666.2021","volume":"322","author":"J Auchampach","year":"2022","unstructured":"Auchampach J, Han L, Huang GN, K\u00fchn B, Lough JW, O\u2019Meara CC, et al. Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration. Am J Physiol Heart Circ Physiol. 2022;322(4):H579\u201396.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"625_CR132","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ymthe.2017.03.027","volume":"25","author":"S Yl\u00e4-Herttuala","year":"2017","unstructured":"Yl\u00e4-Herttuala S, Baker AH. Cardiovascular gene therapy: past, present, and future. Mol Ther. 2017;25(5):1095\u2013106.","journal-title":"Mol Ther"},{"issue":"18","key":"625_CR133","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.jacc.2009.12.044","volume":"55","author":"R Gao","year":"2010","unstructured":"Gao R, Zhang J, Cheng L, Wu X, Dong W, Yang X, et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol. 2010;55(18):1907\u201314.","journal-title":"J Am Coll Cardiol"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-022-00625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T11:12:27Z","timestamp":1678533147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-022-00625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1007\/s40291-022-00625-y","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"25 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NIH R01 HL142627, HL156855, and AHA 20TPA35490001.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}